title: Tobacco-use cessation programs and policies at the University of Manitoba's faculty of dentistry.
abstract: The deleterious effects of tobacco use on general health and oral health are well documented. While one-third of Manitobans are current smokers, up to 79% report they want to quit. Counselling by health care professionals can help achieve quit rates of 15-20%. Yet many health professionals do not provide tobacco-use cessation counselling because they feel they are not trained to do so. In 1998, the faculty of dentistry of the University of Manitoba implemented a number of tobacco-use cessation interventions in its undergraduate curricula and general teaching clinic. The faculty has also successfully obtained the inclusion of a dental fee code for tobacco-use cessation services in the provincial fee guide and has received approval to allow dentists who have completed an approved course in tobacco-use cessation training to prescribe bupropion HCl (Zyban), in consultation with a patient's physician, to aid smoking cessation.
authors: Department of Dental Diagnostic and Surgical Sciences, Faculty of Dentistry, University of Manitoba, 780 Bannatyne Ave., Winnipeg, MB R3E 0W2. shirley_gelskey@umanitoba.ca
authors: S C
authors: SC
authors: Gelskey
mesh_terms: D016642:Bupropion / Q000008:administration & dosage; D003479:Curriculum; D018765:Dopamine Uptake Inhibitors / Q000008:administration & dosage; D004497:Education, Dental; D005179:Faculty, Dental; D017144:Focus Groups; D006801:Humans; D008350:Manitoba; D016134:Organizational Policy; D012017:Referral and Consultation; D012575:Schools, Dental; D012953:Societies, Dental; D013663:Teaching / Q000379:methods; D020340:Tobacco Use Cessation / Q000379:methods*
chemical_list: D018765:Dopamine Uptake Inhibitors; D016642:Bupropion